Nanomedicines Alliance Industry Symposium
Nanomedicines: Charting a Roadmap to Commercialization
On 6-7 March 2013, the Nanomedicines Alliance held an Industry Symposium: Charting a Road to Commercialization. The Symposium addressed:
- desigining nanomedicines
- preclinical pharmacology
- chemistry, manufacturing & controls
- toxicology/ADME and
- clinical studies
through podium presentations, breakouts sessions and poster sessions.
A white paper on the Symposium, Nanomedicine Drug Development: A Scientific Symposium Entitled Charting a Roadmap to Commercialization, has been published in the AAPS Journal.